UNSPSC 51162303: Acetaminophen/aspirin/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162303 Acetaminophen/aspirin/phenylpropanolamine is a Commodity code, but recent state and local opportunities posted under it do not align with the nominal scope. The Washington State Department of Corrections RFQ 13020, due October 7, 2026, solicits parenteral products, services, and equipment — including TPN and PPN solutions, intravenous products, and controlled substances for incarcerated individuals — rather than over-the-counter pain relievers or cold remedies. The Seminole County, Florida IFB 60459723LAS solicits naloxone and drug deactivation systems, also outside the code's stated commodity. State and local governments appear to be using this code for pharmaceutical procurement more broadly, but the recent opportunities show little activity directly matching acetaminophen, aspirin, or phenylpropanolamine products.

The issuing bodies are a state department of corrections (Washington) and a county health procurement office (Seminole County, Florida), suggesting the code may be tagged for clinical and public-health pharmaceutical buys. The Washington DOC opportunity reflects the largest scope: eight correctional facilities across three regions, with DOC selecting multiple contractors (up to three per region) for an initial term running November 26, 2026 through June 30, 2030. The contract requires 24-hour delivery of customized parenteral nutrition bags and 8-hour delivery of other parenteral products; all contractors must hold Washington State business licensure, pass NCIC clearance, and maintain $1–2 million in general liability and professional liability coverage. The Seminole County procurement (with a stale due date of July 26, 2023) requires quarterly deliveries of 1,900 naloxone units and 800 deactivation systems annually. The code shows limited recent relevant activity for the acetaminophen, aspirin, and phenylpropanolamine products it nominally describes.